EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics’ electronic imaging
EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics electronic imaging catheter with Jomeds stent and balloon devices. The two firms hope their combined product will decrease post-angioplasty complications and streamline interventional procedures. Jomed anticipates marketing the device in early 1999, pending CE Mark approval.
In other EndoSonics news, the company announced that it has agreed to a five-year hiatus in its intellectual property claim litigation with Intravascular Research of the U.K. The temporary truce includes closing a Delaware lawsuit between the companies involving patent infringement disputes.
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.